G1 is backed by experienced healthcare investors. We have raised three rounds of capital to advance our product development programs.
- October 2013: $12.5 million Series A led by MedImmune Ventures and Hatteras Venture Partners
- February 2015: $33 million Series B led by Eshelman Ventures and RA Capital Management
- May 2016: $50 million Series C led by Cormorant Asset Management
Cormorant Asset Management